【ChiCTR2100051780】LOO GUO HOU: please submit the latter of ethics approval Lap Sleeve Gastrectomy with Cruroplasty (C-LSG) Versus Lap Sleeve Gastrectomy Alone in Symptomatic GERD Associated with Morbid Obesity. A Randomised Controlled Trial.
ChiCTR2100051780
结束
/
/
/
2021-10-03
/
/
MORBID OBESITY WITH GERD
LOO GUO HOU: please submit the latter of ethics approval Lap Sleeve Gastrectomy with Cruroplasty (C-LSG) Versus Lap Sleeve Gastrectomy Alone in Symptomatic GERD Associated with Morbid Obesity. A Randomised Controlled Trial.
Lap Sleeve Gastrectomy with Cruroplasty (C-LSG) Versus Lap Sleeve Gastrectomy Alone in Symptomatic GERD Associated with Morbid Obesity. A Randomised Controlled Trial.
56000
to test whether LSG with crura reinforcement can be used as an intervention for GERD post LSG
随机平行对照
Ⅲ期
block randomisation
Not stated
NONE
/
100
/
2015-02-01
2020-09-30
/
Patients with BMI more than 27.5 kg/m2 with co-morbidities, and all patients with BMI more than 32.5 kg/m2 were selected for this study (13).;
请登录查看Patients with severe symptomatic GERD and patients with grade IV Hiatus Hernia (HH) were excluded.;
请登录查看Mohd Firdaus Che Ani
47000
Mohd Firdaus Che Ani的其他临床试验
马来西亚Universiti Kebangsaan Malaysia Medical Centre的其他临床试验
- LOO GUO HOU: please submit the latter of ethics approval Lap Sleeve Gastrectomy with Cruroplasty (C-LSG) Versus Lap Sleeve Gastrectomy Alone in Symptomatic GERD Associated with Morbid Obesity. A Randomised Controlled Trial.
- MANAGEMENT OF NON-HEALING WOUNDS IN ASIAN PATIENTS WITH ADJUVANT TOPICAL HAEMOGLOBIN SPRAY. A CASE SERIES.
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29
